As biotechnology and pharmaceutical professionals continue efforts to make advances in medicinal drug formulation, safety and efficacy, experts in the field are implementing innovations to address regulatory hurdles, research costs and global health challenges.
The new Biotech and Pharmaceutical Management Program offered through the Cornell Jeb E. Brooks School of Public Policy is designed to give leaders the opportunity to explore industry trends and cutting edge research with a cohort of peers, executives and renowned faculty from the university.
Read the full story on the Cornell Chronicle.
Torie Anderson
Writer for eCornell
Latest posts by Torie Anderson (see all)
- Shape the Future of Senior Living Management - August 16, 2023
- Cornell introduces new AI-focused Board Governance program - August 9, 2023
- Second MSBA cohort completes residency - August 1, 2023